Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas. - Test2 - elhamkhani - TriplyDB

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

http://www.wikidata.org/entity/Q33376932

about

Can anthracycline therapy for pediatric malignancies be less cardiotoxic?Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells

P2860

Q37785821-5B1FC800-E3F4-4262-85FE-18E9550452C3 Q58798568-55EEFEBC-0365-44E6-B3D0-F2516623B8F8

P2860

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

http://www.wikidata.org/entity/Q33376932

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

@ast

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

@en

type

label

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

@ast

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

@en

prefLabel

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

@ast

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

@en

P1433

Q33376932-54951733-26D7-4801-A5B2-9369236235EF

P1476

Q33376932-5EAD3AD6-F101-4ABD-937F-E074F890C1FB

P2093

Q33376932-326FAFB8-4293-416C-9723-20EA4991AE8F

Q33376932-DC4673B4-806F-4279-8FB1-980ECFB15CD2

P2860

Q33376932-15C5A9E6-4B43-4717-BD51-A4D5696B2D28

Q33376932-30A6CCA8-1B31-4592-A3DA-AE356657573A

Q33376932-3FD1A5E9-F7CA-40B9-AFEF-51CA65837AFA

Q33376932-82A4B8CB-0CAB-45D5-93DC-93B20E4E9279

Q33376932-8669A0EA-885A-433E-A456-8A8FE399B8F6

Q33376932-B2314896-0EF2-43F1-B4D8-A9E9095F65FA

Q33376932-C227739B-6CA8-401E-8A83-9D52E7F8A487

Q33376932-EAC99B3A-17C4-40A4-B0D6-B08F86228AD1

Q33376932-FE42A9BB-BECA-4650-A880-92DA522FFFF9

P304

Q33376932-B161DEC7-8C94-416B-AE62-2B0F2E247A74

P31

Q33376932-1FF96DAB-4A9F-4357-8FB8-B270BCD6E824

P356

Q33376932-9E792BAF-4AFE-426A-A7A6-54EA06CA30B5

P407

Q33376932-0752D3B6-8919-4181-9130-C3E1E0CD699C

P433

Q33376932-120E3581-CBE9-4FD7-9BBC-D71D5D122959

P478

Q33376932-71D2B94B-6844-428F-9DF7-3A3F8F44972D

P577

Q33376932-B4D1BBCB-8C65-4FDA-BFE2-829EBAF1E7C7

P698

Q33376932-2BA76289-71AE-460D-B90D-62EA7144CEC2

P356

13543784.16.10.1683

P1433

Expert Opinion on Investigational Drugs

P1476

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

@en

P2093

Barry W Hancock

http://www.w3.org/2001/XMLSchema#string

Loaie M El-Helw

http://www.w3.org/2001/XMLSchema#string

P2860

A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weekly.

Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: a study of the cancer and acute leukemia group B.

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

The evolving role of etoposide in the management of lymphomas and Hodgkin's disease.

Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.

Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma.

Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis.

ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.

Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: comparative studies against doxorubicin and mitoxantrone.

P304

1683-1691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.16.10.1683

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17922631

http://www.w3.org/2001/XMLSchema#string